ASH News Daily 2013 - Day 2 - (Page B-2)

T:10" S:9" innovation takes inspiration The scientists at Novo Nordisk are some of the world's leaders in proteins, assays, and hematology. Inspired each day to innovate on behalf of people with hemophilia, they are committed to finding solutions that will help patients achieve better treatment outcomes. However, our commitment goes well beyond the laboratory. From improving access to expert care in developing countries, to inspiring community advocacy, to groundbreaking psychosocial research, our innovation aims to make positive change for people living with hemophilia. Visit booth #1939 to find out how Novo Nordisk is changing possibilities in hemophilia. Meet and greet Stephanie Seremetis, Hemophilia CMO Whether it's to answer questions, engage in discussion, or share a quick hello, meet Novo Nordisk Hemophilia Chief Medical Officer (CMO) Stephanie Seremetis during the conference. Visit the Novo Nordisk booth for specific times. Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, New Jersey 08536 U.S.A. Changing Possibilities in Hemophilia® is a registered trademark of Novo Nordisk Health Care AG. © 2013 Novo Nordisk Printed in the U.S.A. 0913-00018160-1 December 2013 NNPC3J0080_ASH_DailyNewsAd_INNOVATION_r7.indd 1 10/11/13 9:30 AM T:14" S:13" NOVO NORDISK SCIENTISTS AND PEOPLE WITH HEMOPHILIA AND THEIR FAMILIES 

Table of Contents for the Digital Edition of ASH News Daily 2013 - Day 2

Table of Contents

ASH News Daily 2013 - Day 2

https://www.nxtbookmedia.com